An estimated seven to ten million people worldwide are living with Parkinson’s disease (PD), which is an incurable and progressive disease of the nervous system affecting movement and cognitive function. More than half of PD patients develop progressive disease showing signs of dementia similar to Alzheimer’s disease. A research team at University of Copenhagen, Denmark, has discovered that non-inheritable PD may be caused by functional changes in the immune regulating gene Interferon-beta (IFN?). Treatment with IFN?-gene therapy successfully prevented neuronal death and disease effects in an experimental model of PD. The results have just been published in prestigious scientific journal Cell.
Protein regulates waste management in nerve cells
The human brain consists of approximately 100 billion neurons, which coordinate activities in all parts of the body. At Biotech Research and Innovation Centre (BRIC), University of Copenhagen, the group of Professor Shohreh Issazadeh-Navikas has discovered that the immune gene IFN? plays a vital role in keeping neurons healthy.
-We found that IFN? is essential for neurons ability to recycle waste proteins. Without this, the waste proteins accumulate in disease-associated structures called Lewy bodies and with time the neurons die, explains assistant professor Patrick Ejlerskov, the first author of this report.
The research team found that mice missing IFN? developed Lewy bodies in parts of the brain, which control body movement and restoration of memory, and as a result they developed disease and clinical signs similar to patients with PD and dementia with Lewy bodies (DLB).
New understanding of non-familial Parkinson’s disease
While hereditary gene mutations have long been known to play a role in familial PD, the study from BRIC offers one of the first models for so-called non-familial PD, which comprises the majority (90-95%) of patients suffering from PD. According to professor Shohreh Issazadeh-Navikas the new knowledge opens new therapeutic possibilities:
–This is one of the first genes found to cause pathology and clinical features of non-familial PD and DLB, through accumulation of disease-causing proteins. It is independent of gene mutations known from familial PD and when we introduced IFN?-gene therapy, we could prevent neuronal death and disease development. Our hope is that this knowledge will enable development of more effective treatment of PD, says professor Shohreh Issazadeh-Navikas.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Good Girl Bad Girl, Michael Robotham's latest novel, is a vivid psychological thrilleron January 17, 2020 at 10:25 am
Michael Robotham is much admired for his psychological crime thrillers featuring clinical psychologist Joe O'Loughlin, who battles Parkinsons disease while helping police investigate complex crimes.
- At 10.8% CAGR, Neurostimulation Devices Market Size Set to Register 8335.5 million USD by 2025on January 17, 2020 at 5:43 am
Market Study Report has released a new research study on Neurostimulation Devices market Analysis 2020-2025 inclusive of one or more factors covering regional opportunities, application landscape, ...
- FA under pressure to follow Scotland's move towards ban on heading in training for children aged under 12on January 16, 2020 at 2:44 pm
The Glasgow research found differences between specific neurological diseases and dementia types, with former players respectively five, four and twice as likely to die of Alzheimer’s, Motor Neurone ...
- Parkinsons Disease Drugs Market 2020 | North America, Europe & Asia Pacific Regions to Dominate the Global Industryon January 15, 2020 at 9:19 pm
The Parkinsons Disease Drugs Market report offers insights into the latest trends. It summarizes key aspects of the market, with focus on leading key players, areas that have witnessed the highest ...
- Gut bacteria could guard against Parkinson's, study findson January 14, 2020 at 8:32 am
For further information, please contact: Shane Canning, Press and PR Office, University of Edinburgh 0131 650 2238, [email protected] For England media enquiries, please contact: Tara Macpherson, ...
- MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson's Diseaseon January 14, 2020 at 5:19 am
THIS MANAGEMENT COMMENTARY SPEAKS ONLY AS OF THE DATE HEREOF AND THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO UPDATE THIS COMMENTARY IN THE FUTURE. View original ...
- The Zacks Analyst Blog Highlights: Advanced Micro Devices, Intel, NVIDIA, Qualcomm and Uberon January 13, 2020 at 8:33 am
Chicago, IL – January 13, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks ...
- Brain Implants Market To Witness Comprehensive Growth by 2029on January 13, 2020 at 12:26 am
Rising demand in Depression, Epilepsy, ParkinsonS Disease, Essential Tremor, Chronic Pain and AlzheimerS Disease applications is prognosticated to propel the growth of the global brain implants market ...
- The Best of CES 2020on January 10, 2020 at 4:01 pm
and the ExoBeam walking aid for Parkinsons patients. Fitness products like the Amazfit HomeStudio (a smart treadmill) and Echelon Row were other interesting products in this group. Robotics also made ...
- 'The charity do great work' - Scott Brown proud to auction Vale and Man City shirtson January 9, 2020 at 8:53 am
Scott is inviting bids for his gloves, his Vale shirt signed by all the players and staff, plus Bravo's shirt to raise funds for Parkinsons UK. He said this afternoon that he is just happy to be in a ...
via Bing News